title: [Assessment and truth -- how many cardio- and cerebrovascular events are in fact to be led back to taking rofecoxib].
authors.forename: Bernd
authors.initials: B
authors.lastname: Mühlbauer
authors.forename: Jürgen
authors.initials: J
authors.lastname: Timm
mesh_terms: D002318:Cardiovascular Diseases / Q000139:chemically induced*; D002561:Cerebrovascular Disorders / Q000139:chemically induced*; D016001:Confidence Intervals; D018849:Controlled Clinical Trials as Topic; D052246:Cyclooxygenase 2 Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D019992:Databases as Topic; D006801:Humans; D007783:Lactones / Q000008:administration & dosage / Q000009:adverse effects*; D009203:Myocardial Infarction / Q000139:chemically induced; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D013450:Sulfones / Q000008:administration & dosage / Q000009:adverse effects*; D013997:Time Factors
chemical_list: D052246:Cyclooxygenase 2 Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib